Actively Recruiting
Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2025-08-15
500
Participants Needed
1
Research Sites
469 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to develop the deep learning-based system that integrates multimodal information to automatically diagnose, stage, and grade thyroid-associated ophthalmopathy (TAO), assist in treatment decision-making, and predict patient prognosis, thereby providing novel tools to support clinical management.
CONDITIONS
Official Title
Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Normal participants without eyelid disorders (control group)
- Patients with thyroid-associated ophthalmopathy (TAO group)
- Cooperative participants
You will not qualify if you...
- Participants with pupil or cornea disorders
- Participants with history of eye injury
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Juan Ye
Hangzhou, Zhejiang, China, 310000
Actively Recruiting
Research Team
J
Juan Ye
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here